試す 金 - 無料
Analytical instrument & pharma spectroscopy equipment
Chronicle Pharmabiz
|October 16, 2025
THE analytical instrument is a device that enables analytical measurements to be carried out automatically and objectively. It helps analysts to work out composition, characterize samples, separate mixtures, yield useful and accurate results.
The instruments are often broken down into component parts such as electronic signal modifier, e.g. filter or amplifier; signal generator, e.g. radiation source; input transducer/detector; and output transducer, e.g. computer. The instruments measure critical process parameters such as pH, conductivity in a wide variety of applications for reliable monitoring.
Applications of analytical instruments are connected with a variety of fields not only in laboratory areas, but also in areas such as pharmaceutical analysis; materials characterization and research; life science research of metabolomics, genomics, proteomics; and clinical analysis.
An analytical scientist should have precise knowledge about various types of analytical instruments, analytical procedures, principles and techniques as well as a strong theoretical knowledge of the fundamental science behind them. This enables critical thinking and an understanding behind the techniques used, something that distinguishes the analytical scientist's difference from other scientists.
Analytical scientists also need to be able to critically evaluate an issue or problem held up and decide on the best course of action taking into account time people and sample turnaround, cost, availability of people and instruments, accuracy and knowledge of any knock-on effects or consequences that the result will have and this is the analytical procedure.
Analytical method development
Analytical method development involves the evaluation and selection of the most precise assay procedures to determine the composition of a drug. Thus, analytical method development and validation is tremendously important for a drug development programme.
Analytical procedures are developed to test specific characteristics of the substances against the predefined acceptance criteria for characteristics.
このストーリーは、Chronicle Pharmabiz の October 16, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Chronicle Pharmabiz からのその他のストーリー
Chronicle Pharmabiz
Home-grown CAR-T cell therapies gaining ground
INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.
4 mins
November 27, 2025
Chronicle Pharmabiz
NPPA extends price fixation on orthopaedic implants for 1 year
IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.
1 mins
November 27, 2025
Chronicle Pharmabiz
FICCI envisages it's Smart AAMs to boost healthcare
In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.
1 min
November 27, 2025
Chronicle Pharmabiz
DoP asked to bring policy for affordable drug pricing
THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.
1 mins
November 27, 2025
Chronicle Pharmabiz
Ramaiah emphasises need for bone health and osteoporosis diagnosis
RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.
2 mins
November 27, 2025
Chronicle Pharmabiz
Nathealth calls for action in 2026-27 Union Budget
NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.
1 mins
November 27, 2025
Chronicle Pharmabiz
Hotspots & growth opportunities in biomanufacturing
THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.
3 mins
November 27, 2025
Chronicle Pharmabiz
Omega Hospitals acquires Cytecare Hospitals
Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.
2 mins
November 27, 2025
Chronicle Pharmabiz
Devices sector hails withdrawal of QCOs
THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.
1 min
November 27, 2025
Chronicle Pharmabiz
'There is urgent need for tech-focused regulatory approach for med devices'
THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.
2 mins
November 27, 2025
Listen
Translate
Change font size
